Perspective
Published on 25 Nov 2022
Engaging patients and citizens in digital health technology development through the virtual space
in Regulatory Affairs
Frontiers in Medical Technology
doi 10.3389/fmedt.2022.958571
- 5,863 views
- 10 citations
Type at least 3 characters
61 articles
Articles
Original Research
Published on 21 Nov 2022
Brazilian breast cancer patient-reported outcomes: What really matters for these women
in Regulatory Affairs
Frontiers in Medical Technology
doi 10.3389/fmedt.2022.809222
- 1,857 views
- 2 citations
Original Research
Published on 13 Sep 2022
Infections and hospital bed-days among aging adults: A five-year retrospective study in a Belgian general hospital
in Regulatory Affairs
Frontiers in Medical Technology
doi 10.3389/fmedt.2022.912469
- 1,578 views
- 5 citations
Policy and Practice Reviews
Published on 05 Sep 2022
Value assessment of medicinal products by the Italian Medicines Agency (AIFA) and French National Authority for Health (HAS): Similarities and discrepancies
in Regulatory Affairs
Frontiers in Medical Technology
doi 10.3389/fmedt.2022.917151
- 7,193 views
- 3 citations
Policy and Practice Reviews
Published on 16 Jun 2022
A Proposal for Value-Based Managed Entry Agreements in an Environment of Technological Change and Economic Challenge for Publicly Funded Healthcare Systems
in Regulatory Affairs
Frontiers in Medical Technology
doi 10.3389/fmedt.2022.888404
- 6,292 views
- 12 citations
Review
Published on 28 Mar 2022
Optimization of Anti-SARS-CoV-2 Neutralizing Antibody Therapies: Roadmap to Improve Clinical Effectiveness and Implementation
in Regulatory Affairs
Frontiers in Medical Technology
doi 10.3389/fmedt.2022.867982
- 5,538 views
- 14 citations
Perspective
Published on 24 Feb 2022
Where National Medicines Policies Have Taken Us With Patient Involvement and Health Technology Assessment in Africa
in Regulatory Affairs
Frontiers in Medical Technology
doi 10.3389/fmedt.2022.810456
- 6,738 views
- 3 citations
Perspective
Published on 24 Feb 2022
Solving the Evidence Interpretability Crisis in Health Technology Assessment: A Role for Mechanistic Models?
in Regulatory Affairs
Frontiers in Medical Technology
doi 10.3389/fmedt.2022.810315
- 3,023 views
- 5 citations
Original Research
Published on 26 Jan 2022
Reconstructing the Effectiveness of Policy Measures to Avoid Next-Wave COVID-19 Infections and Deaths Using a Dynamic Simulation Model: Implications for Health Technology Assessment
in Regulatory Affairs
Frontiers in Medical Technology
doi 10.3389/fmedt.2021.666581
- 4,124 views
- 3 citations
Perspective
Published on 25 Jan 2022
Can We Afford to Exclude Patients Throughout Health Technology Assessment?
in Regulatory Affairs
Frontiers in Medical Technology
doi 10.3389/fmedt.2021.796344
- 4,889 views
- 8 citations
Original Research
Published on 21 Jan 2022
Patient Involvement in the Health Technology Assessment Process in Taiwan
in Regulatory Affairs
Frontiers in Medical Technology
doi 10.3389/fmedt.2021.732160
- 4,339 views
- 1 citation
Original Research
Published on 05 Jan 2022
In vitro Characterization of Anti-SARS-CoV-2 Intravenous Immunoglobulins (IVIg) Produced From Plasma of Donors Immunized With the BNT162b2 Vaccine and Its Comparison With a Similar Formulation Produced From Plasma of COVID-19 Convalescent Donors
in Regulatory Affairs
Frontiers in Medical Technology
doi 10.3389/fmedt.2021.772275
- 3,212 views
- 7 citations
Policy and Practice Reviews
Published on 24 Dec 2021
Patient and Citizen Participation in the Identification of Ethical Considerations Aiming to Address Uncertainty in the Evaluation of Promising Interventions in a Pandemic Context
in Regulatory Affairs
Frontiers in Medical Technology
doi 10.3389/fmedt.2021.794003
- 2,161 views
- 1 citation
Perspective
Published on 20 Dec 2021
Innovative Patient Involvement During Covid-19: Keeping Patients at the Heart of HTA
in Regulatory Affairs
Frontiers in Medical Technology
doi 10.3389/fmedt.2021.793119
- 2,254 views
- 7 citations
Opinion
Published on 30 Nov 2021
The Place and Importance of Patients in Deliberative Processes
in Regulatory Affairs
Frontiers in Medical Technology
doi 10.3389/fmedt.2021.794695
- 1,502 views
- 2 citations
Original Research
Published on 14 Oct 2021
Powered Respirators Are Effective, Sustainable, and Cost-Effective Personal Protective Equipment for SARS-CoV-2
in Regulatory Affairs
Frontiers in Medical Technology
doi 10.3389/fmedt.2021.729658
- 6,606 views
- 3 citations